Baxter International Inc
BAX31.010USD
-0.160-0.51%
交易中 （美东）报价延迟15分钟
15.84B总市值
亏损市盈率 TTM
关于 Baxter International Inc 公司
百特国际公司是一家全球医疗科技公司。其部门包括医疗产品和疗法、医疗保健系统和技术以及制药。医疗产品和疗法部门包括其无菌静脉注射液、输液系统、给药装置、肠外营养疗法和手术止血剂、密封剂和防粘连产品的销售。医疗保健系统和技术部门包括其互联护理解决方案和协作工具的销售，包括智能床系统、患者监测系统和诊断技术、呼吸健康设备和先进的手术空间设备，包括手术室集成技术、精密定位设备和其他配件。制药部门包括特种注射药物、吸入麻醉和药物配制的销售。它提供诊断、重症监护、营养、医院和外科产品组合。
公司简介
公司代码BAX
公司名称Baxter International Inc
上市日期May 15, 1961
成立日期1931
CEOMr. D. Brent Shafer
员工数量38000
证券类型Ordinary Share
年结日May 15
公司地址One Baxter Parkway
城市DEERFIELD
上市交易所NYSE Consolidated
国家United States of America
邮编60015
电话12249482000
网址https://www.baxter.com/
公司代码BAX
上市日期May 15, 1961
成立日期1931
公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Heather Knight
Ms. Heather Knight
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
177.32K
+11.79%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
130.30K
+15.20%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
118.15K
+10.70%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
28.52K
+2.77%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
23.05K
+2.74%
Ms. Patricia B. Morrison
Ms. Patricia B. Morrison
Independent Director
Independent Director
15.76K
-25.89%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
9.27K
+2.46%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
3.47K
--
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
787.00
-88.29%
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Heather Knight
Ms. Heather Knight
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
177.32K
+11.79%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
130.30K
+15.20%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
118.15K
+10.70%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
28.52K
+2.77%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
23.05K
+2.74%
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Infusion Therapies and Technologies
4.10B
38.58%
Care and Connectivity Solutions
1.81B
17.06%
Injectables and Anesthesia
1.37B
12.91%
Front Line Care
1.14B
10.69%
Advanced Surgery
1.10B
10.38%
Other
1.10B
10.39%
地区USD
名称
营收
占比
United States
5.85B
55.00%
International
4.79B
45.00%
业务
地区
业务USD
名称
营收
占比
Infusion Therapies and Technologies
4.10B
38.58%
Care and Connectivity Solutions
1.81B
17.06%
Injectables and Anesthesia
1.37B
12.91%
Front Line Care
1.14B
10.69%
Advanced Surgery
1.10B
10.38%
Other
1.10B
10.39%
股东统计
更新时间: 18 小时前
更新时间: 18 小时前
持股股东
股东类型
持股股东
股东统计
占比
The Vanguard Group, Inc.
11.80%
Dodge & Cox
10.06%
Pzena Investment Management, LLC
6.56%
BlackRock Institutional Trust Company, N.A.
5.76%
State Street Global Advisors (US)
4.25%
Other
61.58%
持股股东
股东统计
占比
The Vanguard Group, Inc.
11.80%
Dodge & Cox
10.06%
Pzena Investment Management, LLC
6.56%
BlackRock Institutional Trust Company, N.A.
5.76%
State Street Global Advisors (US)
4.25%
Other
61.58%
股东类型
股东统计
占比
Investment Advisor/Hedge Fund
53.40%
Investment Advisor
32.35%
Research Firm
2.70%
Hedge Fund
2.37%
Pension Fund
2.23%
Insurance Company
1.44%
Bank and Trust
1.13%
Sovereign Wealth Fund
1.00%
Individual Investor
0.36%
Other
3.01%
机构持股
更新时间: 2月20日 周四
更新时间: 2月20日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q1
1902
499.25M
97.33%
-40.58M
2024Q4
1984
501.11M
97.98%
-41.68M
2024Q3
2005
485.40M
95.14%
-42.32M
2024Q2
2042
472.72M
92.77%
-47.98M
2024Q1
2091
469.13M
92.11%
-57.76M
2023Q4
2137
471.69M
92.98%
-44.04M
2023Q3
2123
465.39M
91.91%
-35.52M
2023Q2
2140
458.55M
90.66%
-30.65M
2023Q1
2123
459.27M
90.86%
-22.24M
2022Q4
2132
456.58M
90.57%
-21.28M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
60.53M
11.8%
+468.84K
+0.78%
Dec 31, 2024
Dodge & Cox
51.58M
10.06%
+1.20M
+2.39%
Feb 28, 2025
Pzena Investment Management, LLC
33.64M
6.56%
+1.42M
+4.39%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
29.53M
5.76%
-652.43K
-2.16%
Dec 31, 2024
State Street Global Advisors (US)
21.79M
4.25%
+12.21K
+0.06%
Dec 31, 2024
BlackRock Financial Management, Inc.
17.57M
3.43%
+1.23M
+7.54%
Dec 31, 2024
T. Rowe Price Associates, Inc.
15.25M
2.97%
+1.13M
+8.03%
Dec 31, 2024
Geode Capital Management, L.L.C.
12.45M
2.43%
+290.28K
+2.39%
Dec 31, 2024
Harris Associates L.P.
8.46M
1.65%
-1.31M
-13.43%
Dec 31, 2024
Columbia Threadneedle Investments (US)
7.28M
1.42%
-2.29M
-23.93%
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
Parnassus Value Select ETF
5.07%
Cullen Enhanced Equity Income ETF
3.53%
iShares Large Cap Value Active ETF
2.45%
Global X S&P 500 Quality Dividend ETF
2%
iShares U.S. Medical Devices ETF
1.92%
Invesco S&P 500 Equal Weight Health Care ETF
1.76%
SPDR S&P Health Care Equipment ETF
1.52%
First Trust Indxx Medical Devices ETF
1.27%
ROBO Global Healthcare Technology & Innovation ETF
0.98%
Humankind US Stock ETF
0.85%
查看更多
Parnassus Value Select ETF
占比5.07%
Cullen Enhanced Equity Income ETF
占比3.53%
iShares Large Cap Value Active ETF
占比2.45%
Global X S&P 500 Quality Dividend ETF
占比2%
iShares U.S. Medical Devices ETF
占比1.92%
Invesco S&P 500 Equal Weight Health Care ETF
占比1.76%
SPDR S&P Health Care Equipment ETF
占比1.52%
First Trust Indxx Medical Devices ETF
占比1.27%
ROBO Global Healthcare Technology & Innovation ETF
占比0.98%
Humankind US Stock ETF
占比0.85%
分红派息
近5年累计派现
2.75B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 11, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option
Feb 28, 2025
Apr 01, 2025
Feb 28, 2025
Nov 11, 2024
BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option
Nov 29, 2024
Jan 02, 2025
Nov 29, 2024
Jul 16, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option
Aug 30, 2024
Oct 01, 2024
Aug 30, 2024
May 07, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option
May 31, 2024
Jul 01, 2024
May 31, 2024
Feb 12, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option
Mar 01, 2024
Apr 01, 2024
Feb 29, 2024
Nov 14, 2023
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option
Dec 01, 2023
Jan 02, 2024
Nov 30, 2023
Jul 18, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option
Sep 01, 2023
Oct 02, 2023
Aug 31, 2023
May 01, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 03, 2023 going ex on Jun 01, 2023
Jun 02, 2023
Jul 03, 2023
Jun 01, 2023
Feb 14, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 03, 2023 going ex on Feb 23, 2023 with reinvestment option
Feb 24, 2023
Apr 03, 2023
Feb 23, 2023
Nov 15, 2022
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 03, 2023 going ex on Dec 01, 2022
Dec 02, 2022
Jan 03, 2023
Dec 01, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据